BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
PRODID:iCalendar-Ruby
BEGIN:VEVENT
SEQUENCE:0
CONTACT:richard.collins@bio2business.com
ORGANIZER:Bio2Business Ltd
DTEND:20070904T200000
DTSTART:20070904T093000
UID:2009-11-27T14:43:07-05:00_951392466@socialweb1
DTSTAMP:20091127T144307
DESCRIPTION:Welcome to the Biotech Outsource Strategies series of forums or
 ganised and run by Bio2Business Ltd (www.bio2business.com). BOS is the evol
 ution of an ongoing 3 year project by Bio2Business Ltd to facilitate R&D ou
 tsourcing and partnering for international biotech and pharmaceutical compa
 nies.
\n
\n*_A Day of Partnering & Networking_*
\nBOS is primarily a partne
 ring event\; a forum to connect international biotech & pharma outsource ex
 ecutives with a network of specialist CROs. BOS2007 has a clear focus on sm
 all molecule drug discovery/development. As a delegate attending BOS in Lon
 don you can expect to meet with a significant number of top quality niche g
 lobal CROs at the discovery/development interface who offer high quality\, 
 reliable services. You will be able to organise 1 to 1 meetings  with CROs\
 , consultants and fellow development executives as you wish throughout the 
 day using Bio2Business partnering software. Informal networking over coffee
 \, lunch and closing drinks receptions will give you an ideal opportunity t
 o make links with fellow discovery/development executives and exchange idea
 s and approaches to outsourcing.
\n
\n*_Speaker Programme_*
\nIn addition t
 o providing a partnering forum for discovery & development attendees\, BOS 
 also strives to deliver an outstanding programme of speakers to deliver per
 spective and approaches in the field of drug discovery & development. This 
 year we are pleased to announce a first class programme of speakers includi
 ng\; Professor Peter Jenner\, CSO Proximagen Neurosciences \; Professor Gra
 ham Richards\, Professor of Chemistry Oxford University\; Dr Andy Merritt\,
  Director of Discovery Medicinal Chemistry GlaxoSmithKline\; Dr Dave Ennis\
 , acting Director of Chemistry\, AstraZeneca\; Hooshang Zavareh\, Managing 
 Director of ChemPharmaServe Ltd and Dr Alan Davidson\, Director of Pre-Clin
 ical Development Chroma Therapeutics.
\n
\nOur Speakers are international e
 xperts in their areas of specialisation including targeted validation\, com
 putational chemistry\, medicinal chemistry and process R&D. Equally as impo
 rtant we are very pleased to wellcome the following chairs for our discover
 y\, development and case study modules\; Dr Chris Hill\, Senior VP Research
  Organon Laboratories Ltd\; Prof Hans Jurgen Federsel\, Director of Science
  Global Process R&D AstraZeneca & Sue Jackson\, Principal Consultant Wood M
 ackenzie Ltd. 
\n
\nWe believe we have the right blend between academia\, b
 iotech\, pharma and service industry to make for an excellent day of discus
 sion\, debate and knowledge transfer which will run in parallel to one to o
 ne meetings that you wish to organise.
\n
\n*_Why attend BOS 2007?_*
\n• Ne
 twork with your peers from international biotech & pharma discovery/develop
 ment.
\n• Exchange ideas and transfer knowledge with regards to successful 
 outsourcing.
\n• Hear from leading authorities in key areas of discovery & 
 development such as target validation\, computational chemistry\, medicinal
  chemistry & process R&D.
\n• Organise 1:1 meetings with leading discovery/
 development CROs & industry consultants.
\n
SUMMARY:Biotech Outsource Strategies (BOS)
LAST-MODIFIED:20070726T160310
CREATED:20070726T155722
END:VEVENT
END:VCALENDAR